The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea.
BACKGROUND
The etiology and pathogenesis of keratoconus remain unclear, and therefore we decided to study the distribution of different isoforms of tenascin (Tn) and fibronectin (Fn) in normal human corneas and in those obtained from penetrating keratoplasty for keratoconus and corneal scarring.


METHODS
Frozen sections of human cornea and conjunctiva were stained by immunohistochemical methods with a panel of monoclonal antibodies (MAbs) against different isoforms of Tn and Fn.


RESULTS
In the normal human eye, Tn was found in the limbal and conjunctival basement membrane region, in the conjunctival blood vessels and at the junction of the cornea and sclera, but no immunoreaction was seen in the normal cornea. In the corneas from the keratoconus patients, a clear immunoreaction for Tn was seen in the defects of Bowman's membrane as well as in the distorted stroma beneath the defects. In some of the keratoconus corneas, basement membrane adjacent to the defects also showed reactivity for Tn, and in clinically and histologically scarred keratoconus corneas the scars expressed Tn. In the scarred corneas, only blood vessels in the posterior portion of the cornea showed immunoreactivity for Tn, while no Tn was noted in the scar area or in Bowman's membrane. No major differences were noticed in the reactivity of different MAbs against Tn isoforms. Fn, extradomain A Fn (EDA-Fn) and oncofetal Fn (onc-Fn) were found in the basement membrane of the central cornea of the normal eye. In keratoconus corneas, the defects and clinical and histological scars bound MAbs against Fn, EDA-Fn and onc-Fn, but in the scarred corneas no enhancement in the expression of Fns was noted. Extradomain B cellular Fn (EDB-Fn) was not expressed in any of the eyes studied.


CONCLUSIONS
The results suggest that the anterior portion of the cornea is involved in the pathogenesis of keratoconus. Furthermore, it seems that the expression of Tn and Fns in the clinically scarred keratoconus corneas is due to a process in which both repairing and scar-forming mechanisms operate at the same time. However, the origin of the defects in Bowman's membrane seen in keratoconus still remains unclear. They may be minor scars due to the disease or primary defects in the process leading to keratoconus.
Tuori
A
A
Department of Anatomy, University of Helsinki, Finland.
Virtanen
I
I
Aine
E
E
Uusitalo
H
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D001485:Basement Membrane / Q000378:metabolism; D002921:Cicatrix / Q000378:metabolism* / Q000473:pathology; D003228:Conjunctiva / Q000098:blood supply / Q000378:metabolism; D003315:Cornea / Q000098:blood supply / Q000378:metabolism* / Q000601:surgery; D005353:Fibronectins / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D007640:Keratoconus / Q000378:metabolism* / Q000473:pathology / Q000601:surgery; D015948:Keratoplasty, Penetrating / Q000473:pathology; D008856:Microscopy, Fluorescence; D008875:Middle Aged; D012590:Sclera / Q000098:blood supply / Q000378:metabolism; D019063:Tenascin / Q000276:immunology / Q000378:metabolism*; D014945:Wound Healing / Q000502:physiology
D005353:Fibronectins; D019063:Tenascin